Biofrontera Inc. (BFRIW)Woburn, United States | NasdaqCM
0.03 USD
|
Hot Take ↕ | July 11, 2026, 6:21 a.m. EDT
The immediate outlook is severely bearish due to a complete lack of price history and liquidity, rendering any short-term momentum or technical setup impossible to establish. While the company reports positive revenue growth of 17.4% and maintains a healthy gross margin of 77%, these operational strengths are completely overshadowed by catastrophic financial health indicators. The firm is burning cash aggressively, with operating cash flow at -$9.3 million and free cash flow barely covering $1.5 million against $7.7 million in debt. This results in a massive debt-to-equity ratio of 127 and a return on equity of -339%, signaling deep capital destruction. Furthermore, the stock is trading at a negligible 5.7% of book value, which typically indicates a distressed asset rather than a bargain. With no analyst coverage, no dividend history, and a balance sheet that suggests imminent solvency risks, the investment case is fundamentally broken despite the top-line growth narrative. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 127.249 |
| Revenue per Share | 3.973 |
| Beta | 0.83 |
| Profit Margins | -25.66% |
| Website | https://www.biofrontera-us.com |
| Attribute | Value |
|---|---|
| Address1 | 660 Main Street |
| Address2 | 1st Floor |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 0.825 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 0.511 |
| City | Woburn |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0294 |
| Current Ratio | 1.205 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0294 |
| Day Low | 0.0294 |
| Debt To Equity | 127.249 |
| Display Name | Biofrontera |
| Ebitda | -10,565,000 |
| Ebitda Margins | -0.24455 |
| Eps Trailing Twelve Months | -1.296 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.0294 |
| Fifty Two Week High Change | 0.0 |
| Fifty Two Week High Change Percent | 0.0 |
| Fifty Two Week Low | 0.0294 |
| Fifty Two Week Low Change | 0.0 |
| Fifty Two Week Low Change Percent | 0.0 |
| Fifty Two Week Range | 0.0294 - 0.0294 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,783,690,200,000 |
| Float Shares | 9,080,004 |
| Free Cashflow | 1,477,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 84 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.77288 |
| Gross Profits | 33,389,000 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,021-10-29 |
| Language | en-US |
| Long Business Summary | Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts. |
| Long Name | Biofrontera Inc. |
| Market | us_market |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_531568773 |
| Net Income To Common | -11,085,000 |
| Open | 0.0971 |
| Operating Cashflow | -9,314,000 |
| Operating Margins | -0.38953 |
| Phone | 781 245 1325 |
| Previous Close | 0.0294 |
| Price Hint | 4 |
| Price To Book | 0.05753425 |
| Profit Margins | -0.25659 |
| Quick Ratio | 0.995 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 0.0294 |
| Regular Market Day Low | 0.0294 |
| Regular Market Day Range | 0.0294 - 0.0294 |
| Regular Market Open | 0.0971 |
| Regular Market Previous Close | 0.0294 |
| Regular Market Price | 0.0294 |
| Regular Market Time | 1,783,951,864 |
| Regular Market Volume | 267 |
| Return On Assets | -0.32414 |
| Return On Equity | -3.39043 |
| Revenue Growth | 0.174 |
| Revenue Per Share | 3.973 |
| Sand P52 Week Change | 0.20847368 |
| Sector | |
| Sector Key | |
| Short Name | Biofrontera Inc. Warrants |
| Source Interval | 15 |
| State | MA |
| Symbol | BFRIW |
| Total Cash | 6,326,000 |
| Total Cash Per Share | 0.494 |
| Total Debt | 7,724,000 |
| Total Revenue | 43,201,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.296 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 267 |
| Website | https://www.biofrontera-us.com |
| Zip | 1,801 |